Dimethyl sulfoxide therapy as toxicity-reducing agent and potentiator of cyclophosphamide in the treatment of different types of cancer.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D006885:Hydroxybutyrates; D005680:gamma-Aminobutyric Acid; D003520:Cyclophosphamide; D004121:Dimethyl Sulfoxide